Inquiry Basket
BOC Sciences provides various cytotoxin that act as payloads to conjugate with antibodies and form ADCs. The Nuclear Factor Kappa-B (NF-KB) family consists of transcription factors that play complex and essential roles in regulating immune responses and inflammation. Recently, NF-KB has generated considerable interest as it implicated in human cancer initiation, progression and resistance of treatment. The NF-KB can be activated by various intra- and extra-cellular stimuli, such as cytokines, oxidant-free radicals, ultraviolet irradiation, bacterial and viral products. Activated NF-KB translocates into the nucleus and stimulates gene expression involved in a wide variety of biological functions. Inappropriate activation of NF-KB has been associated with various inflammatory diseases, while persistent inhibition of NF-KB leads to inappropriate immune cell development or delayed cell growth. Nevertheless, NF-KB is a critical regulator of the immediate-early response to viral infection.
Comprehensive one-stop antibody-drug conjugate service platform
Large Stock
More than 1000+ high-purity products in inventory
Global Delivery
Warehouses in multiple cities to ensure fast delivery
mg to kg
Qualified facilities & equipment of cGMP laboratory
24/7 Technical Support
Strict process parameter control to ensure product quality
Irregular activation of the Nuclear Factor Kappa-B (NF-KB) transcription system contributes to cancer progression and threatens bone health. Several major components of the NF-KB pathway, such as NF-KB1 and NF-KB2 subunits, can stimulate the transcription of proliferation regulating genes (e.g., cyclin D1 and c-myc) involved in metastasis, VEGF-dependent angiogenesis and cell immortality. Furthermore, NF-KB activation can also induce the expression of cytidine deaminase (AID) and APOBEC proteins, creating a mechanistic link between the NF-KB pathway and mutagenic characteristics of cervical cancer. Inhibition of NF-KB can potentially be used to reverse resistance to radiotherapy and systemic anti-cancer medication, but no clinically proven NF-KB targeting strategy is available currently.
The Nuclear Factor Kappa-B (NF-KB) is essential for coordinating inflammatory responses, including innate immunity, adaptive immunity, cellular differentiation, proliferation, and survival in almost all multicellular organisms. Therefore, the NF-KB system is tightly regulated, and irregulation of NF-KB has been implicated in a wide range of diseases ranging from inflammatory and immune disorders to cancers. As a result, the NF-KB regulatory network and its dynamics offer a multitude of promising therapeutic targets that remain to be fully explored and translated into clinical use. However, to untapped the potential for finer-grained therapeutic targeting of the NF-KB signaling system requires a quantitative understanding of dynamical control and integration of various physiological and pathological signals and stimuli. Aeruginosin-865 (Aer-865), isolated from the terrestrial cyanobacterium Nostoc sp, is the first aeruginosin-type peptide containing both fatty acid and a carbohydrate moiety. Confocal laser scanning microscopy revealed that the anti-inflammatory effect of Aer-865 was directly associated with inhibition of NF-KB translocation to the nucleus.
References：
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.
